Sergey Gorbanev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergey Gorbanev has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andrei Kolotilshchikov
Botkin Hospital
2 shared publications - Aleksei Ankin
Russian Medical Academy of Continuous Professional Education
1 shared publication - G. M. Chechenin
Botkin Hospital
1 shared publication - L. N. Voloschenko
S.P. Botkin City Clinical Hospital 5
1 shared publication - M. Z. Eminov
Botkin Hospital
1 shared publication - Serghei Covantsev
Department of Surgical Oncology, Federal State Autonomous Institution National Medical Research Centre “Treatment and Rehabilitation Centre” of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 19 August 2025
- Published by Iberoamerican Journal of Medicine in Iberoamerican Journal of Medicine
- Vol. 7 (4) , 129-131
Gastric diverticulum: a rare incidental finding during computed tomography
Iberoam J Med, vol.7, n4, p.129-131, 2025
- 19 August 2025
- Published by Iberoamerican Journal of Medicine in Iberoamerican Journal of Medicine
- Vol. 7 (4) , 129-131
Open AccessGastric diverticulum: a rare incidental finding during computed tomography
Iberoam J Med, vol.7, n4, p.129-131, 2025
- Open Access
- 15 April 2024
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 13 (1) , 72-78
Liver Abscesses in Patients Who Have Had a New Coronavirus Infection
Aim of study To analyze clinical, laboratory, instrumental and microbiological data in patients with diagnosed liver abscesses who had previously had a new coronavirus infection.Material and methods An analysis of the work carried out with 13 patients who received treatment at the surgical clinic of the Botkin Hospital in the emergency surgical department No. 76 from September 2021 to October 2022 for liver abscesses and previous COVID-19 is presented.Results All presented patients were comprehensively examined. Surgical intervention was performed — transcutaneous drainage of liver abscesses under ultrasound guidance. Positive changes were revealed in the course of complex therapy, including antibacterial (based on the Results of a microbiological study with determination of the sensitivity of the flora to antibacterial drugs), anti-inflammatory, and daily sanitation of the abscess cavity. All patients were discharged for outpatient follow-up treatment in stable, satisfactory condition. Nine patients (69.2%) were discharged with drain under the supervision of clinic doctors. In 5 patients (30.8%) with regression of the abscess cavity, drainage from the abscess cavity was removed before discharge.Conclusion Patients with previous COVID-19 may develop liver abscesses. It is important to conduct thorough diagnostic measures in patients who present with fever and (or) abdominal pain after a coronavirus infection. Further prospective studies are needed, including morphological assessment of liver changes (upon autopsy in case of death).
- 15 April 2024
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 13 (1) , 72-78
Open AccessLiver Abscesses in Patients Who Have Had a New Coronavirus Infection
Aim of study To analyze clinical, laboratory, instrumental and microbiological data in patients with diagnosed liver abscesses who had previously had a new coronavirus infection.Material and methods An analysis of the work carried out with 13 patients who received treatment at the surgical clinic of the Botkin Hospital in the emergency surgical department No. 76 from September 2021 to October 2022 for liver abscesses and previous COVID-19 is presented.Results All presented patients were comprehensively examined. Surgical intervention was performed — transcutaneous drainage of liver abscesses under ultrasound guidance. Positive changes were revealed in the course of complex therapy, including antibacterial (based on the Results of a microbiological study with determination of the sensitivity of the flora to antibacterial drugs), anti-inflammatory, and daily sanitation of the abscess cavity. All patients were discharged for outpatient follow-up treatment in stable, satisfactory condition. Nine patients (69.2%) were discharged with drain under the supervision of clinic doctors. In 5 patients (30.8%) with regression of the abscess cavity, drainage from the abscess cavity was removed before discharge.Conclusion Patients with previous COVID-19 may develop liver abscesses. It is important to conduct thorough diagnostic measures in patients who present with fever and (or) abdominal pain after a coronavirus infection. Further prospective studies are needed, including morphological assessment of liver changes (upon autopsy in case of death).